Because MSI-H tumors are more genetically unstable than MSS tumors, MSI-H CRCs tend to accumulate mutations in various oncogenes and tumor suppressor genes, including BRAF, CTNNB1, HNF1A, PTEN, BRCA1, and BRCA2 (65, 73). This evidence concerns the gene BRAF and neoplasm.